Global Trust Asset Management LLC trimmed its position in shares of UnitedHealth Group Inc (NYSE:UNH) by 23.4% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 2,325 shares of the healthcare conglomerate’s stock after selling 709 shares during the quarter. Global Trust Asset Management LLC’s holdings in UnitedHealth Group were worth $579,000 at the end of the most recent quarter.

Several other institutional investors have also recently modified their holdings of UNH. IMS Capital Management acquired a new position in UnitedHealth Group during the third quarter worth about $85,000. Worth Venture Partners LLC acquired a new position in UnitedHealth Group during the third quarter worth about $104,000. FNY Investment Advisers LLC acquired a new position in UnitedHealth Group during the third quarter worth about $106,000. Fort L.P. acquired a new position in UnitedHealth Group during the second quarter worth about $119,000. Finally, Polaris Greystone Financial Group LLC acquired a new position in UnitedHealth Group during the third quarter worth about $120,000. Institutional investors and hedge funds own 85.28% of the company’s stock.

Shares of UNH traded up $2.74 on Friday, hitting $247.61. 3,823,457 shares of the stock traded hands, compared to its average volume of 4,239,340. The company has a debt-to-equity ratio of 0.61, a quick ratio of 0.69 and a current ratio of 0.69. The company has a market capitalization of $234.39 billion, a price-to-earnings ratio of 24.59, a PEG ratio of 1.23 and a beta of 0.88. UnitedHealth Group Inc has a 1 year low of $208.48 and a 1 year high of $287.94.

UnitedHealth Group (NYSE:UNH) last posted its quarterly earnings results on Tuesday, October 16th. The healthcare conglomerate reported $3.41 earnings per share for the quarter, topping the Zacks’ consensus estimate of $3.30 by $0.11. The company had revenue of $56.56 billion for the quarter, compared to the consensus estimate of $56.34 billion. UnitedHealth Group had a net margin of 5.71% and a return on equity of 23.62%. UnitedHealth Group’s revenue was up 12.4% on a year-over-year basis. During the same quarter last year, the firm posted $2.66 earnings per share. Equities analysts expect that UnitedHealth Group Inc will post 12.81 EPS for the current fiscal year.

The business also recently declared a quarterly dividend, which was paid on Thursday, December 13th. Shareholders of record on Monday, December 3rd were paid a dividend of $0.90 per share. This represents a $3.60 dividend on an annualized basis and a yield of 1.45%. The ex-dividend date of this dividend was Friday, November 30th. UnitedHealth Group’s dividend payout ratio is currently 35.75%.

Several analysts have issued reports on the stock. Zacks Investment Research downgraded shares of UnitedHealth Group from a “buy” rating to a “hold” rating in a report on Thursday, November 29th. Oppenheimer upped their price target on shares of UnitedHealth Group from $295.00 to $300.00 and gave the company an “outperform” rating in a report on Wednesday, November 28th. Raymond James set a $310.00 price target on shares of UnitedHealth Group and gave the company a “buy” rating in a report on Wednesday, November 28th. Bank of America upped their price target on shares of UnitedHealth Group from $315.00 to $320.00 and gave the company a “buy” rating in a report on Wednesday, October 17th. Finally, Piper Jaffray Companies upped their price target on shares of UnitedHealth Group to $312.00 and gave the company an “overweight” rating in a report on Wednesday, November 28th. One investment analyst has rated the stock with a hold rating and twenty-two have assigned a buy rating to the company. UnitedHealth Group has an average rating of “Buy” and an average price target of $292.33.

In other UnitedHealth Group news, Director Kenneth Irwin Shine sold 163 shares of the stock in a transaction that occurred on Friday, November 9th. The shares were sold at an average price of $274.83, for a total transaction of $44,797.29. The transaction was disclosed in a filing with the SEC, which is available at this link. Also, Director Richard T. Burke sold 6,090 shares of the stock in a transaction that occurred on Wednesday, November 28th. The stock was sold at an average price of $281.72, for a total transaction of $1,715,674.80. Following the transaction, the director now directly owns 1,711,584 shares in the company, valued at approximately $482,187,444.48. The disclosure for this sale can be found here. Company insiders own 0.87% of the company’s stock.

COPYRIGHT VIOLATION NOTICE: “UnitedHealth Group Inc (UNH) Stake Lessened by Global Trust Asset Management LLC” was published by The Cerbat Gem and is the sole property of of The Cerbat Gem. If you are viewing this piece of content on another site, it was illegally stolen and reposted in violation of U.S. and international copyright and trademark law. The legal version of this piece of content can be viewed at https://www.thecerbatgem.com/2019/01/11/unitedhealth-group-inc-unh-stake-lessened-by-global-trust-asset-management-llc.html.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. It operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight, and OptumRx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older, addressing their needs for preventive and acute health care services, as well as services dealing with chronic disease and other specialized issues for older individuals; and Medicaid plans, Children's Health Insurance Program, and health care programs; and health and dental benefits.

Recommended Story: Front-End Load

Institutional Ownership by Quarter for UnitedHealth Group (NYSE:UNH)

Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.